The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Open accessAbstract
The molecular pathogenesis of pediatric astrocytomas is still poorly understood. To further understand the genetic abnormalities associated with these tumors, we performed a genome-wide analysis of DNA copy number aberrations in pediatric low-grade astrocytomas by using array-based comparative genomic hybridization. Duplication of the BRAF protooncogene was the most frequent genomic aberration, and tumors with BRAF duplication showed significantly increased mRNA levels of BRAF and a downstream target, CCND1, as compared with tumors without duplication. Furthermore, denaturing HPLC showed that activating BRAF mutations were detected in some of the tumors without BRAF duplication. Similarly, a marked proportion of low-grade astrocytomas from adult patients also had BRAF duplication. Both the stable silencing of BRAF through shRNA lentiviral transduction and pharmacological inhibition of MEK1/2, the immediate downstream phosphorylation target of BRAF, blocked the proliferation and arrested the growth of cultured tumor cells derived from low-grade gliomas. Our findings implicate aberrant activation of the MAPK pathway due to gene duplication or mutation of BRAF as a molecular mechanism of pathogenesis in low-grade astrocytomas and suggest inhibition of the MAPK pathway as a potential treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Prevalence of ras gene mutations in human colorectal cancers
Bos, J. L., Fearon, E. R., Hamilton, S. R., Vries, M. V., van Boom, J. H., van der Eb, A. J., & Vogelstein, B. (1987) · Nature · doi:10.1038/327293a0 · Cited by 1,860
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Kimura, E. T., Nikiforova, M. N., Zhu, Z., Knauf, J. A., Nikiforov, Y. E., & Fagin, J. A. (2003) · PubMed · Cited by 1,510
Ohgaki, H., & Kleihues, P. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.479 · Cited by 1,381
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224
Lichter, P., Cremer, T., Borden, J., Manuelidis, L., & Ward, D. C. (1988) · Human Genetics · doi:10.1007/bf01790090 · Cited by 1,160
Self-citationBRAF and RAS mutations in human lung cancer and melanoma.
Brose, M. S., Volpe, P., Feldman, M. D., Kumar, M. S., Rishi, I., Gerrero, R. M., Einhorn, E., Herlyn, M., Minna, J. D., Nicholson, A. G., et al. (2002) · PubMed · Cited by 1,048
Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances
Solinas-Toldo, S., Lampel, S., Stilgenbauer, S., Nickolenko, J., Benner, A., Döhner, H., Cremer, T., & Lichter, P. (1997) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199712)20:4<399::aid-gcc12>3.0.co;2-i · Cited by 1,002
Self-citationHermanson, M., Funa, N. S., Hartman, M., Claesson, L., Heldin, C., Westermark, B., & Nistér, M. (1992) · PubMed · Cited by 705
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
Pandit, B., Sarkozy, A., Pennacchio, L. A., Carta, C., Oishi, K., Martinelli, S., Pogna, E. A., Schackwitz, W., Ustaszewska, A., Landstrom, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2073 · Cited by 698
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome
Niihori, T., Aoki, Y., Narumi, Y., Neri, G., Cavé, H., Verloes, A., Okamoto, N., Hennekam, R. C. M., Gillessen-Kaesbach, G., Wieczorek, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1749 · Cited by 599
Bubendorf, L., Kononen, J., Koivisto, P. A., Schraml, P., Moch, H., Gasser, T. C., Willi, N., Mihatsch, M. J., Sauter, G., & Kallioniemi, O. (1999) · PubMed · Cited by 594
Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations
Listernick, R., Ferner, R. E., Liu, G. T., & Gutmann, D. H. (2007) · Annals of Neurology · doi:10.1002/ana.21107 · Cited by 576
Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome
Rodriguez-Viciana, P., Tetsu, O., Tidyman, W. E., Estep, A. L., Conger, B. A., Cruz, M. S., McCormick, F., & Rauen, K. A. (2006) · Science · doi:10.1126/science.1124642 · Cited by 571
Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1923 · Cited by 509
Germline gain-of-function mutations in RAF1 cause Noonan syndrome
Razzaque, M. A., Nishizawa, T., Komoike, Y., Yagi, H., Furutani, M., Amo, R., Kamisago, M., Momma, K., Katayama, H., Nakagawa, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2078 · Cited by 498
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer
Ciampi, R., Knauf, J. A., Kerler, R., Gandhi, M., Zhu, Z., Nikiforova, M. N., Rabes, H. M., Fagin, J. A., & Nikiforov, Y. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523237 · Cited by 461
High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
Xu, X., Quiros, R. M., Gattuso, P., Ain, K. B., & Prinz, R. A. (2003) · PubMed · Cited by 415
van den Boom, J., Wolter, M., Kuick, R., Misek, D. E., Youkilis, A. S., Wechsler, D. S., Sommer, C., Reifenberger, G., & Hanash, S. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63463-3 · Cited by 307
Self-citation(1997) · PubMed · Cited by 256
Clinical and Molecular Characteristics of Malignant Transformation of Low-Grade Glioma in Children
Broniscer, A., Baker, S. J., West, A. N., Fraser, M. M., Proko, E., Kocak, M., Dalton, J., Zambetti, G. P., Ellison, D. W., Kun, L. E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8213 · Cited by 237
Mendrzyk, F., Radlwimmer, B., Joos, S., Kokocinski, F., Benner, A., Stange, D. E., Neben, K., Fiegler, H., Carter, N. P., Reifenberger, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8589 · Cited by 213
Self-citationStops along the RAS pathway in human genetic disease
Bentires-Alj, M., Kontaridis, M. I., & Neel, B. G. (2006) · Nature Medicine · doi:10.1038/nm0306-283 · Cited by 190
Freier, K., Joos, S., Flechtenmacher, C., Devens, F., Benner, A., Bosch, F. X., Lichter, P., & Hofele, C. (2003) · PubMed · Cited by 186
Self-citationWright, J. H., Munar, E., Jameson, D. R., Andreassen, P. R., Margolis, R. L., Seger, R., & Krebs, E. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11335 · Cited by 175
Distinct Genetic Signatures among Pilocytic Astrocytomas Relate to Their Brain Region Origin
Sharma, M. K., Mansur, D. B., Reifenberger, G., Perry, A., Leonard, J. R., Aldape, K. D., Albin, M. G., Emnett, R. J., Loeser, S., Watson, M. A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-0973 · Cited by 175
Self-citationRosenberg, D. W., Yang, S., Pleau, D. C., Greenspan, E. J., Stevens, R. G., Rajan, T. V., Heinen, C. D., Levine, J., Zhou, Y., & O'Brien, M. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0343 · Cited by 171
Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas
Knobbe-Thomsen, C. B., REIFENBERGER, J., & Reifenberger, G. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0929-9 · Cited by 156
Self-citationRoberts, E. C., Shapiro, P. S., Nahreini, T. S., Pagès, G., Pouysségur, J., & Ahn, N. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7226-7241.2002 · Cited by 141
Weber, R. G., Hoischen, A., Ehrler, M., Zipper, P., Kaulich, K., Blaschke, B., Becker, A. J., Weber‐Mangal, S., Jauch, A. T., Radlwimmer, B., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209851 · Cited by 118
Self-citationZielinski, B., Kappler‐Gratias, S., Toedt, G., Mendrzyk, F., Stange, D. E., Radlwimmer, B., Lohmann, D. R., & Lichter, P. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20186 · Cited by 117
Self-citationJeuken, J. W. M., den Broecke, C. V., Gijsen, S. J., Boots‐Sprenger, S., & Wesseling, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0239-0 · Cited by 111
Analysis of pilocytic astrocytoma by comparative genomic hybridization
Sanoudou, D., Tingby, O., Ferguson-Smith, M. A., Collins, V. P., & Coleman, N. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1066 · Cited by 101
Yunoue, S., Tokuo, H., Fukunaga, K., Feng, L., Ozawa, T., Nishi, T., Kikuchi, A., Hattori, S., Kuratsu, J., Saya, H., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209413200 · Cited by 100
Raf-1/MEK/MAPK Pathway Is Necessary for the G2/M Transition Induced by Nocodazole
Hayne, C. C., Tzivion, G., & Luo, Z. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002766200 · Cited by 98
Knauf, J. A., Ouyang, B., Knudsen, E. S., Fukasawa, K., Babcock, G. F., & Fagin, J. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511690200 · Cited by 93
Mutation analysis of B-RAF gene in human gliomas
Basto, D., Trovisco, V., Lopes, J. M., Martins, A. M., Pardal, F., Soares, P., & Reis, R. M. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0936-x · Cited by 90
Jones, D., Ichimura, K., Liu, L., Pearson, D. M., Plant, K., & Collins, V. P. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240465.33628.87 · Cited by 86
Dessars, B., Raeve, L. E. D., Housni, H. E., Debouck, C., Sidon, P. J., Morandini, R., Roseeuw, D. I., Ghanem, G., Vassart, G., & Heimann, P. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700725 · Cited by 84
Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas
Cheng, Y., Pang, J. C., Ng, H., Ding, M., Zhang, S., Zheng, J., Liu, D., & Poon, W. (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.01005.x · Cited by 81
Further Evidence for a Somatic KRAS Mutation in a Pilocytic Astrocytoma
Janzarik, W. G., Kratz, C., Loges, N. T., Olbrich, H., Klein, C., Schäfer, T., Scheurlen, W. G., Roggendorf, W., Weiller, C., Niemeyer, C. M., et al. (2007) · Neuropediatrics · doi:10.1055/s-2007-984451 · Cited by 71
Self-citationRorive, S., Maris, C., Debeir, O., Sandras, F., Vidaud, M., Bièche, I., Salmon, I. J., & Decaestecker, C. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000228203.12292.a1 · Cited by 58
An unexpected new role of mutant Ras: perturbation of human embryonic development
Kratz, C. P., Niemeyer, C. M., & Zenker, M. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0135-4 · Cited by 57
Self-citationGrade II astrocytomas are subgrouped by chromosome aberrations
Hirose, Y., Aldape, K., Chang, S. M., Lamborn, K. R., Berger, M. S., & Feuerstein, B. G. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00791-4 · Cited by 53
Cytogenetics in pediatric low‐grade astrocytomas
Orr, L. C., Fleitz, J. M., McGavran, L., Wyatt‐Ashmead, J., Handler, M. S., & Foreman, N. K. (2002) · Medical and Pediatric Oncology · doi:10.1002/mpo.1305 · Cited by 34
Cited by
Recurrent BRAF mutations in Langerhans cell histiocytosis
Badalian-Very, G., Vergilio, J.-A., Degar, B. A., MacConaill, L. E., Brandner, B., Calicchio, M. L., Kuo, F. C., Ligon, A. H., Stevenson, K. E., Kehoe, S. M., et al. (2010) · Blood · doi:10.1182/blood-2010-04-279083 · Cited by 1,243
Weller, M., Wick, W., Aldape, K., Brada, M., Berger, M., Pfister, S. M., Nishikawa, R., Rosenthal, M., Wen, P. Y., Stupp, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.17 · Cited by 1,124
Self-citationSchindler, G., Capper, D., Meyer, J., Janzarik, W., Omran, H., Herold-Mende, C., Schmieder, K., Wesseling, P., Mawrin, C., Hasselblatt, M., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0802-6 · Cited by 1,034
Self-citationJones, D. T. W., Kocialkowski, S., Liu, L., Pearson, D. M., Bäcklund, L. M., Ichimura, K., & Collins, V. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2097 · Cited by 944
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2013) · Nature Genetics · doi:10.1038/ng.2611 · Cited by 835
Metadata
- Authors
- Pfister, S., Janzarik, W. G., Remke, M., Ernst, A., Werft, W., Becker, N., Toedt, G., Wittmann, A., Kratz, C., Olbrich, H., Ahmadi, R., Thieme, B., Joos, S., Radlwimmer, B., Kulozik, A., Pietsch, T., Herold-Mende, C., Gnekow, A., Reifenberger, G., Korshunov, A., Scheurlen, W., Omran, H., & Lichter, P.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-05-01
- Volume
- 118
- Issue
- 5
- Pages
- 1739-1749
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2126595521
- Cited by
- 523
- References
- 48
- FWCI
- 15.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.